ClinVar Miner

Submissions for variant NM_002473.5(MYH9):c.3340T>C (p.Ser1114Pro) (rs200901330)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine RCV000151335 SCV000199309 likely benign not specified 2017-04-27 criteria provided, single submitter clinical testing p.Ser1114Pro in exon 26 of MYH9: This variant is not expected to have clinical significance because it has been identified in 0.1% (10/10128) of Ashkenazi Jewi sh chromosomes and in 0.05% (68/126464) of European chromosomes by the Genome Ag gregation Database (gnomAD,; dbSNP rs200901330) , which is higher than expected based on the estimated prevalence of 1-9/1,000,0 00 of MYH9-related disorder (, MYH9-related disease, Orpha:182050).
Illumina Clinical Services Laboratory,Illumina RCV000363597 SCV000438396 likely benign MYH9-related disorder 2016-06-14 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000268989 SCV000438397 likely benign Nonsyndromic Hearing Loss, Dominant 2016-06-14 criteria provided, single submitter clinical testing
GeneDx RCV000767070 SCV000617832 uncertain significance not provided 2017-07-28 criteria provided, single submitter clinical testing The S1114P variant in the MYH9 gene has been reported previously in association with MYH9-related disease, however, some of these individuals also harbored an additional disease causing variant on the same MYH9 allele (Heath et al., 2001; Saposnik et al., 2014). The S1114P variant is observed in 33/65,036 (0.05%) alleles from individuals of non-Finnish European background in the ExAC dataset (Lek et al., 2016). The S1114P variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved in mammals, however, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret S1114P as a variant of uncertain significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.